Teach me leukemias and lymphomas in detail with pneumonics to learn it

Reading File

Finding Sources

Reading File

Finding Sources

Searching Images

leukemia blood smear lymphoblast

Peripheral blood smear from a patient with suspected chronic lymphocytic leukemia (CLL) shows a predominance of small, mature-appearing lymphocytes with scant cytoplasm and clumped nuclear chromatin, accompanied by fragile cells that readily disrupt during smear preparation, producing numerous smudge or basket cells visible on the slide. The image depicts a single smudge cell in the upper right, with numerous small darkly staining lymphocytes occupying the field. The smear was prepared with Wright-Giemsa stain and examined under light microscopy at high magnification (approximately 1000x total magnification with oil immersion). Clinically, CLL is defined by absolute mature lymphocytosis of ≥5.0 × 10^9/L sustained for ≥3 months, often asymptomatic and detected incidentally on complete blood count. Morphology alone is insufficient for diagnosis; immunophenotyping showing co-expression of CD5, CD19, CD23 with weak surface immunoglobulin and light chain restriction supports CLL diagnosis. Smudge cells result from fragile leukemic cells and reflect underlying cytoskeletal fragility, though they are not specific. The image illustrates typical features: monomorphic lymphocytes, scant cytoplasm, condensed chromatin, and absent prominent nucleoli. This finding has diagnostic significance, guiding further workup, including flow cytometry, cytogenetics, and molecular studies, to distinguish CLL from other chronic lymphoproliferative disorders such as small lymphocytic lymphoma (SLL), mantle cell lymphoma, prolymphocytic leukemia, and reactive lymphocytosis.

$Peripheral blood smear prepared from a patient with suspected plasma cell leukemia (PCL) was examined by bright‑field light microscopy after Wright‑Giemsa staining. The smear shows several circulating plasma‑cell–like elements, including four conspicuous proplasmacytes with dispersed nuclear chromatin and prominent nucleoli, as indicated by arrows in the original figure. In addition, background erythrocytes exhibit rouleaux formation, a common feature in paraproteinemic states. The cells display eccentrically placed nuclei with pronounced basophilic cytoplasm and a coarse chromatin pattern; occasional cells show a perinuclear clearing (Golgi rim) suggestive of plasmacytic differentiation. Immunoglobulin light‑chain restriction is not determined on this smear alone but flow cytometry or immunohistochemistry would typically confirm clonal plasma cells. Relative proportions indicate that neoplastic plasma cells constitute a substantial fraction of leukocytes, consistent with plasma cell leukemia rather than reactive plasmacytosis. PCL is an aggressive myelomatous process often presenting with cytopenias, organomegaly, and sometimes lymphadenopathy; prognosis is poor, and treatment responsiveness is limited. This image illustrates characteristic morphologic features used for differential diagnosis against multiple myeloma, Waldenström macroglobulinemia, and other causes of plasmacytosis. Clinically relevant keywords include plasma cells, rouleaux, Wright‑Giemsa stain, 100X oil, peripheral blood, leukemia, myeloma, and hematologic malignancy.$

Peripheral blood smear prepared from a patient with suspected plasma cell leukemia (PCL) was examined by bright‑field light microscopy after Wright‑Giemsa staining. The smear shows several circulating plasma‑cell–like elements, including four conspicuous proplasmacytes with dispersed nuclear chromatin and prominent nucleoli, as indicated by arrows in the original figure. In addition, background erythrocytes exhibit rouleaux formation, a common feature in paraproteinemic states. The cells display eccentrically placed nuclei with pronounced basophilic cytoplasm and a coarse chromatin pattern; occasional cells show a perinuclear clearing (Golgi rim) suggestive of plasmacytic differentiation. Immunoglobulin light‑chain restriction is not determined on this smear alone but flow cytometry or immunohistochemistry would typically confirm clonal plasma cells. Relative proportions indicate that neoplastic plasma cells constitute a substantial fraction of leukocytes, consistent with plasma cell leukemia rather than reactive plasmacytosis. PCL is an aggressive myelomatous process often presenting with cytopenias, organomegaly, and sometimes lymphadenopathy; prognosis is poor, and treatment responsiveness is limited. This image illustrates characteristic morphologic features used for differential diagnosis against multiple myeloma, Waldenström macroglobulinemia, and other causes of plasmacytosis. Clinically relevant keywords include plasma cells, rouleaux, Wright‑Giemsa stain, 100X oil, peripheral blood, leukemia, myeloma, and hematologic malignancy.

This brightfield light microscopy image depicts a dense bone marrow aspirate smear stained with hematoxylin and eosin. The cellularity is high with a uniform population of small to medium-sized lymphoid cells (lymphoblast-like cells) occupying much of the field. Nuclei are round to ovoid with finely dispersed, coarse chromatin, and scant basophilic cytoplasm; nucleoli are inconspicuous. The architecture is diffuse rather than follicular, with little evidence of erythroid or myeloid precursors; occasional mitotic figures may be present but are not prominent at this magnification. The histology shows a monotonous lymphoid infiltrate, a pattern that raises concern for a lymphoblastic process. Pathologic interpretation would emphasize lymphoid blasts consistent with acute lymphoblastic leukemia or lymphoblastic lymphoma; however, definitive classification requires ancillary studies such as flow cytometry immunophenotyping, immunohistochemistry, and genetic studies (cytogenetics/molecular). Clinically, such a pattern correlates with acute presentations: cytopenias, signs of marrow failure, fatigue, infections, or organomegaly. Potential uses include medical education for recognizing quantitative lymphoid blasts on bone marrow smears, training in differential diagnoses of monomorphic blue cell infiltrates, and optimizing search queries for pathology image datasets. Keywords include: lymphoblasts, pediatric ALL, bone marrow failure, marrow infiltration, hematopathology, immunophenotype, CD markers, prognosis guidance, diagnostic workflow, and educational value overall.

Reading File

Searching Images

Hodgkin lymphoma Reed Sternberg cell histology

This histopathology image depicts a lymph node biopsy showing features diagnostic of lymphocyte-depleted classic Hodgkin lymphoma, reticular subtype. Using light microscopy on an H&E-stained paraffin section, the lymphoid architecture is markedly effaced by a cellular sheet of large, atypical mononuclear cells with prominent nucleoli. Occasional Reed-Sternberg cells are visible within the expansive background, including cells with multilobed or bilobed nuclei and prominent eosinophilic nucleoli, characteristic of Hodgkin lymphoma. The RS cells are scattered among numerous atypical mononuclear variants rather than forming a cohesive nodular structure. There is little-to-no fibrosis and only sparse non-neoplastic inflammatory cells, which is typical for the lymphocyte-depleted pattern. The background may show rimming by small lymphocytes and histiocytes in a reticular network, but overall cellularity is high. Immunophenotypic markers are not shown here, but in clinical practice RS cells typically express CD30 and CD15 with weaker PAX5 or B-cell markers. The diagnostic significance lies in recognizing the lymphocyte-depleted cHL morphology, which carries distinct clinical implications, often presenting with advanced stage disease and systemic symptoms. This image is useful for educational purposes, differential diagnosis conversation, and correlating histology with treatment planning (ABVD/BEACOPP regimens). Correlation with immunohistochemistry (CD30, CD15, PAX5) and EBV status further supports diagnosis in practice.

This brightfield histopathology image depicts a lymph node biopsy illustrating a histiocyte-rich variant of mixed cellularity classical Hodgkin lymphoma. The tissue is sectioned and stained with hematoxylin and eosin, viewed at low-to-intermediate magnification, revealing a densely cellular background with a prominent infiltrate of histiocytes and epithelioid macrophages forming aggregates, accompanied by scattered eosinophils, lymphocytes, plasma cells, and occasional neutrophils. The classic Reed-Sternberg cells are present but may be sparse within the abundant histiocytic milieu, with multilobed nuclei and prominent nucleoli. The architectural pattern is polymorphic rather than nodular, lacking prominent fibrous bands characteristic of nodular sclerosis. The histiocyte-rich variant features abundant macrophages mirroring granulomatous-like features, potentially mimicking inflammatory conditions; however, residual neoplastic Hodgkin cells in this setting bear the typical immunophenotype (CD30+, CD15+, PAX5 weak) in adjacent areas. Clinically, this histology correlates with mixed cellularity Hodgkin lymphoma, a B-cell origin neoplasm presenting with constitutional symptoms and lymphadenopathy. The image is relevant for educational demonstration of HL subtypes, differential diagnoses with non-Hodgkin lymphomas and granulomatous processes, and for training in histopathologic recognition, pattern recognition, and morphologic correlation with immunophenotype and clinical findings. Immunohistochemistry supports diagnosis by highlighting Reed-Sternberg cells (CD30+, CD15+, PAX5 weak) amid a histiocyte-rich background; EBV association may be variable; clinical staging and treatment follow Hodgkin lymphoma guidelines.

This high-power light micrograph of a lymph node biopsy, stained with Hematoxylin and Eosin, demonstrates classical Hodgkin lymphoma histology. The tissue is densely cellular with a polymorphic inflammatory background comprising small lymphocytes, eosinophils, plasma cells, and histiocytes. Scattered among the background are large binucleated Reed-Sternberg (RS) cells exhibiting prominent, mirror-image eosinophilic nucleoli and ample cytoplasm, giving an owl's eye appearance. Mononuclear RS variants with similar nuclear features are present, reflecting heterogeneity within the malignant cell population. The RS cells may appear with delicate nuclear membranes and occasional lobulation. The surrounding milieu often includes reactive T-lymphocytes and occasional eosinophils attracted by cytokines produced by RS cells. The overall architecture lacks well-formed nodules, and the background shows a mixed inflammatory infiltrate, characteristic of classical Hodgkin lymphoma subtypes such as mixed cellularity. Important differential considerations include infectious or benign reactive processes, but the presence of RS cells with classic morphology supports a diagnosis of classical HL. Clinically, these findings correlate with nodal enlargement and B symptoms in many patients, and histology guides staging and therapy decisions, including chemotherapeutic regimens such as ABVD and potential radiotherapy in select cases. Correlation with immunohistochemistry and clinical data improves diagnostic confidence and treatment planning for patient care.

Reading File

Searching Images

CML Philadelphia chromosome BCR-ABL chronic myeloid leukemia

A diagnostic microphotograph of a peripheral blood interphase cell from a patient with Chronic Myeloid Leukemia (CML), analyzed via Fluorescence In Situ Hybridization (FISH). The image demonstrates an atypical BCR-ABL1 translocation pattern using a dual-color, dual-fusion probe. Against the dark blue DAPI-stained nuclear background, four distinct fluorescent signals are visible. The observed configuration is classified as 1F1G2R: one orange/yellow fusion signal (representing the BCR-ABL1 hybrid on the derivative chromosome 22), one green signal (representing the native BCR locus on chromosome 22), and two red signals (representing the native ABL1 locus on chromosome 9). This atypical pattern deviates from the standard 2F1G1R fusion signal usually seen in Philadelphia chromosome-positive cells, indicating clonal evolution or complex chromosomal rearrangements. This image serves as an educational example of cytogenetic variability in hematologic malignancies and the use of FISH for monitoring molecular response in patients undergoing tyrosine kinase inhibitor (TKI) therapy like imatinib.

This diagnostic image displays a fluorescence in situ hybridization (FISH) analysis of human bone marrow cells, used primarily for detecting the BCR-ABL1 gene fusion associated with Chronic Myeloid Leukemia (CML). The image shows two blue-stained nuclei (DAPI) against a dark background. On the left, a larger metaphase cell exhibits a normal signal pattern with two distinct cyan/green signals and two distinct red signals (2G2R), representing the normal location of the ABL1 and BCR genes on their respective chromosomes. On the right, a smaller interphase cell demonstrates a fusion signal where a red and a cyan/green signal overlap or are closely apposed, indicative of a chromosomal translocation. This visual is a key educational tool for demonstrating molecular cytogenetics, specifically the dual-color, dual-fusion probe technique used in hematopathology to identify the Philadelphia chromosome.

I now have comprehensive material to write a detailed, mnemonic-rich teaching guide. Let me compile everything.

🩸 Leukemias and Lymphomas: A Complete Teaching Guide

PART 1: THE BIG PICTURE - Classification

Mnemonic: "ALL AML CML CLL" = "A Marvelous Cancer Causes Long Lingering illness"

Type	Cell Line	Acute/Chronic	Key Age
ALL	Lymphoid	Acute	Children (peak 2-3 yrs)
AML	Myeloid	Acute	Adults (also Down syndrome kids)
CML	Myeloid	Chronic	Adults 30-60 yrs
CLL	Lymphoid	Chronic	Elderly (median age 70)

Quick rule: "A = young, C = old"

Acute leukemias tend to be more aggressive, hit younger patients more (especially ALL in kids)
Chronic leukemias tend to be indolent, hit older adults

PART 2: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Mnemonic for facts: "ALL CATS"

A - Age peak: 2-3 years (most common childhood malignancy, 25% of all pediatric cancers)
L - Lymphoblasts proliferate (bone marrow replaced)
L - Low WBC, Low RBC, Low platelets on CBC (or HIGH WBC with blasts)
C - CALLA positive (CD10+) = best prognosis in B-ALL
A - Auer rods: ABSENT (Auer rods are in AML, not ALL)
T - T-cell ALL = mediastinal mass (thymic) in teenage boys
S - Survival 95% remission rate; 80% disease-free at 5 years

Immunophenotype of B-ALL: "19 good, 10 better"

ALL B-cell subtypes co-express CD19 and/or CD22
CALLA-positive = CD10+ = best prognosis

Chromosomal associations:

Translocation	Significance
t(12;21) TEL-AML1	Most common in children, GOOD prognosis
t(9;22) BCR-ABL (Ph+)	WORST prognosis in ALL; needs TKI + chemo
t(4;11) MLL-AF4	Infant ALL, very poor prognosis
Hyperdiploidy (>50 chromosomes)	Good prognosis
Hypodiploidy (<44 chromosomes)	Poor prognosis

Mnemonic for poor prognosis ALL: "Ph+ MLL = Poor"

Philadelphia chromosome positive = bad
MLL rearrangement (11q23) = bad

Clinical features: "BLAST"

B - Bone pain
L - Lymphadenopathy, hepatosplenomegaly
A - Anemia (pallor, fatigue)
S - Susceptibility to infection (neutropenia)
T - Thrombocytopenic bleeding (petechiae, purpura)

PART 3: ACUTE MYELOID LEUKEMIA (AML)

Mnemonic: "AML = Auer Myeloblast Leukemia"

The pathognomonic finding is Auer rods - needle-like cytoplasmic inclusions in myeloblasts.

WHO/FAB Classification - Mnemonic: "My FAB 8 dishes"

M0 = undifferentiated
M1 = minimal differentiation
M2 = t(8;21) - most common AML in young adults
M3 = Acute Promyelocytic Leukemia (APL) - t(15;17) - treat with ATRA
M4 = myelomonocytic
M5 = monocytic
M6 = erythroleukemia
M7 = megakaryoblastic (Down syndrome!)

The Crown Jewel: APL = M3

Mnemonic: "15 to 17 = PML goes to RAR-α"

t(15;17) fuses PML gene (chromosome 15) with RAR-α (chromosome 17)
Treatment: ATRA (all-trans retinoic acid) - differentiates blasts into mature cells
DIC (disseminated intravascular coagulation) is the deadly complication - watch for it!
Auer rod bundles = "faggot cells" - pathognomonic for M3

Cytogenetic Risk Stratification (European LeukemiaNet):

Mnemonic for FAVORABLE: "8 invites 16 to a good party"

t(8;21) - RUNX1-RUNX1T1
inv(16) or t(16;16) - CBFB-MYH11
Mutated NPM1 without FLT3-ITD
Biallelic mutated CEBPA

Mnemonic for ADVERSE: "3 minus 5 minus 7 = disaster"

inv(3), del(5q), monosomy 7 (-7), -5, complex karyotype
FLT3-ITD high = bad
Mutated RUNX1, ASXL1 = bad

Risk factors for AML: "BRAIN"

B - Benzene exposure
R - Radiation (ionizing)
A - Alkylating chemotherapy (prior)
I - Inherited syndromes (Down, Fanconi anemia, Noonan)
N - Neurofibromatosis

PART 4: CHRONIC MYELOID LEUKEMIA (CML)

THE most testable leukemia fact: "CML = Philadelphia chromosome"

Mnemonic: "9 to 22 = Ph = CML"

t(9;22) translocation = Philadelphia chromosome
Fuses BCR (chromosome 22) with ABL (chromosome 9)
BCR-ABL produces a constitutively active tyrosine kinase

FISH demonstrating BCR-ABL1 fusion - the hallmark of CML and Philadelphia chromosome-positive ALL

Three Phases: "CAB"

C - Chronic phase: Most patients here at diagnosis; indolent, splenomegaly, high WBC with all myeloid cell types
A - Accelerated phase: Increasing blasts (10-19%), resistant disease
B - Blast crisis: >20% blasts - acts like acute leukemia (can be myeloid or lymphoid)

Treatment: Tyrosine Kinase Inhibitors (TKIs)

Mnemonic: "Ima-Da-Nilo-Bo" = generations of TKIs

1st generation: Imatinib (Gleevec) - first approved, landmark drug
2nd generation: Dasatinib, Nilotinib - overcome most imatinib resistance
3rd generation: Bosutinib, Ponatinib - for T315I mutation ("gatekeeper" mutation)

T315I mutation = resistant to all TKIs except Ponatinib - remember: "Pona-T315-only"

Blood film in CML: "All stages on smear"

WBC count massively elevated (50,000-200,000)
Entire myeloid series visible: myeloblasts, promyelocytes, myelocytes, metamyelocytes, bands, segs
Basophilia is characteristic (unique feature!)
Low Leukocyte Alkaline Phosphatase (LAP) score - opposite of leukemoid reaction

PART 5: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Key facts: "CLL = Commoners' Leukemia (western world)"

Most common leukemia in the Western world
Median age 70 years; male > female (2:1)
Rare in Asians (even after emigrating to the West - genetic predisposition)

Classic CLL peripheral smear: monomorphic small lymphocytes + smudge/basket cells (fragile leukemic cells)

Pathognomonic finding: Smudge cells (basket cells)

Fragile CLL cells break during smear preparation
Mnemonic: "CLL cells are fragile - they SMUDGE"

Immunophenotype: "CLL loves CD5"

Mnemonic: "5 in 19 AND 23"

CD5+ (T-cell marker on B-cells - aberrant)
CD19+, CD23+ (B-cell markers)
Weak surface immunoglobulin (dim slg)
Mnemonic: "CD5 is a traitor - a B-cell wearing a T-cell badge"

Staging - Rai (US) and Binet (Europe):

Rai Stages - Mnemonic: "Lymph Anemia Thrombocytopenia" (0→IV)

Stage 0: Lymphocytosis only
Stage I: + Lymphadenopathy
Stage II: + Splenomegaly/hepatomegaly
Stage III: + Anemia
Stage IV: + Thrombocytopenia

Complications: "HART"

H - Hypogammaglobulinemia (infections)
A - Autoimmune hemolytic anemia (AIHA) - warm antibody
R - Richter transformation (→ Diffuse Large B Cell Lymphoma - very poor prognosis)
T - Thrombocytopenia (autoimmune)

Cytogenetics in CLL:

Abnormality	Significance
del(13q14)	Most common; GOOD prognosis
del(11q) ATM	Intermediate
Trisomy 12	Intermediate
del(17p) TP53	WORST prognosis; resistant to chemo

Mnemonic: "13 is lucky (good), 17 is unlucky (bad)"

PART 6: HODGKIN LYMPHOMA (HL)

The Hallmark: Reed-Sternberg (RS) cells

Mnemonic: "RS = Really Scary Owl Eyes"

Large binucleated cells with prominent eosinophilic nucleoli
Classic "owl eye" appearance
RS cells are CD15+, CD30+, PAX5 weak, CD20-

Classical Hodgkin lymphoma - Reed-Sternberg cells with owl-eye nucleoli

Owl-eye Reed-Sternberg cells (large binucleated with eosinophilic nucleoli) in a mixed inflammatory background

Epidemiology: Bimodal age distribution

Mnemonic: "Young and Old - biMODAL"

Peak 1: Late teens/young adults (15-35 yrs)
Peak 2: >55 years
EBV associated in ~50% of cases in the USA

Subtypes: "NLMM" = "No Lymphs Make Me sad" (favorable to unfavorable)

Subtype	Mnemonic	Key Feature	Prognosis
Nodular Lymphocyte Predominant (NLPHL)	"N = Nice"	LP cells (popcorn cells), CD20+, CD15/30-	Best
Nodular Sclerosis (NSHL)	"NS = Not Serious"	Most common (70%), lacunar cells, collagen bands	Good
Mixed Cellularity (MCHL)	"MC = Moderate Concern"	EBV+, diverse infiltrate	Intermediate
Lymphocyte Depletion (LDHL)	"LD = Lethal Danger"	Rarest, aggressive, HIV-associated	Worst

Mnemonic for subtypes: "NNML" - "Nobody Notices Mixed Lesions" (N-S, N-LP, M-C, L-D)

Staging (Ann Arbor): "IALE"

I = 1 lymph node region
II = 2+ regions, same side of diaphragm
III = Both sides of diaphragm
IV = Extranodal/bone marrow involvement

B symptoms (add "B" suffix): Fever >38°C, Night sweats, Weight loss >10% in 6 months

Mnemonic: "B = Bad = Fever, Night sweats, Weight loss" = FNW

Treatment: "ABVD" (standard)

A = Adriamycin (doxorubicin)
B = Bleomycin
V = Vinblastine
D = Dacarbazine

Mnemonic: "A Beautiful Vintage Dance"

PART 7: NON-HODGKIN LYMPHOMA (NHL)

Key principle: "NHL = No RS cells" (unlike Hodgkin)

Common NHL subtypes - Mnemonic: "DUMB-FL"

D - Diffuse Large B Cell Lymphoma (DLBCL) - most common NHL in adults
U - Unknown (many rare types)
M - Mantle Cell Lymphoma (MCL)
B - Burkitt Lymphoma
F - Follicular Lymphoma (FL) - most common indolent NHL
L - Lymphoblastic Lymphoma (T-cell)

1. DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)

Most common NHL (~30-40% of all NHL)
Aggressive but potentially curable
CD20+, CD19+
Treatment: R-CHOP (Rituximab + Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone)

Mnemonic: "R-CHOP = Really Cool Hospital Oncology Protocol"

2. FOLLICULAR LYMPHOMA

Mnemonic: "Follicular = t(14;18) = Bcl-2 turned ON = no apoptosis"

t(14;18) = BCL-2 overexpression = cells don't die
Indolent but incurable with standard chemotherapy
"Waxing and waning" lymphadenopathy
May transform to DLBCL (Richter-like transformation)

3. BURKITT LYMPHOMA

The fastest-growing cancer in humans

Mnemonic: "8 to 14 MYC = BURKing out"

t(8;14) = c-MYC translocation
"Starry sky" pattern on histology (macrophages engulfing apoptotic cells)
Three types: Endemic (Africa, jaw, EBV-related), Sporadic (USA, abdomen), Immunodeficiency-related (HIV)
Mnemonic: "EBV = Endemic/African jaw; HIV = Immunodeficiency"
Tumor lysis syndrome risk is HIGH

4. MANTLE CELL LYMPHOMA

Mnemonic: "Mantle = t(11;14) = Cyclin D1 overexpressed = MANTLED in cyclin"

t(11;14) = CCND1 gene overexpression (cyclin D1)
CD5+, CD19+, CD20+, CD23- (differs from CLL which is CD23+)
Mnemonic to distinguish MCL from CLL: "MCL = minus 23; CLL = plus 23"
Poor prognosis

5. T-CELL LYMPHOBLASTIC LYMPHOMA

Teenage boys, anterior mediastinal mass (SVC syndrome)
Mnemonic: "T for Teenage, Thymus, Thorax"

PART 8: MASTER COMPARISON TABLE

Feature	ALL	AML	CML	CLL
Peak age	Children 2-3 yrs	Adults	Adults 30-60	Elderly >65
Pathognomonic	-	Auer rods	Ph chromosome	Smudge cells
Key marker	CD10 (CALLA)	MPO+	BCR-ABL	CD5+/CD19+/CD23+
Translocation	t(9;22) worst; t(12;21) best	t(15;17) APL = ATRA	t(9;22)	del(13q) good, del(17p) bad
Cure	~80% children	~70%	TKIs - not curative	Incurable, but manageable
Blast crisis risk	-	-	YES (CML→blast crisis)	NO

PART 9: MASTER MNEMONICS SUMMARY CARD

Condition	Key Mnemonic
ALL	"ALL CATS" - Age, Lymphoblasts, Low counts, CALLA, Auer absent, T-cell mediastinal, Survival 95%
AML	"BRAIN" risk factors; Auer rods = AML
APL (M3)	"15 to 17 PML-RARA → ATRA"
CML	"9 to 22 = Ph = CML"; "CAB" phases; "Ima-Da-Nilo-Bo" TKIs
CLL	"CLL = CD5 traitor"; smudge cells; "13 lucky, 17 unlucky"
Hodgkin	"RS = Owl Eyes"; "ABVD = A Beautiful Vintage Dance"
DLBCL	"R-CHOP"
Follicular	"t(14;18) = BCL-2 on = can't die"
Burkitt	"8 to 14 MYC = fastest cancer"; starry sky
Mantle Cell	"t(11;14) = Cyclin D1; CD23 minus"

PART 10: HIGH-YIELD EXAM TRAPS

Auer rods = AML only (never ALL)
Smudge cells = CLL
Reed-Sternberg cells = Hodgkin lymphoma (but RS-like cells can appear in other conditions)
Philadelphia chromosome = CML (also in Ph+ ALL = bad prognosis)
ATRA treatment = APL (M3) only - do NOT use in other AML subtypes
DIC in leukemia = think APL (M3)
Starry sky pattern = Burkitt lymphoma
Popcorn cells (LP cells) = Nodular Lymphocyte Predominant Hodgkin Lymphoma
CD5+ B-cells = CLL or Mantle Cell Lymphoma (distinguish by CD23: CLL is CD23+, MCL is CD23-)
Low LAP score = CML (high LAP = leukemoid reaction from infection)
Jaw mass in African child = Endemic Burkitt lymphoma (EBV-related)
Anterior mediastinal mass in teenage boy = T-cell ALL/lymphoblastic lymphoma

PART 11: BONUS - VISUAL MEMORY AID

"The Leukemia Clock"

       ALL (12 o'clock = young)
         |
CML -----+------ CLL
(3 o'clock         (9 o'clock
= middle-age)      = elderly)
         |
       AML (6 o'clock = any adult)

Top = youngest patients (ALL)
Going clockwise = getting older
Ph chromosome connects CML and ALL (both can have t(9;22))

Sources: Goldman-Cecil Medicine, International Edition; Swanson's Family Medicine Review; Textbook of Family Medicine, 9e

Teach me inflammation acute and chronic in detail and pneumonics to learn the chemical mediators

Reading File

Finding Sources

Reading File

Searching Images

acute inflammation neutrophil emigration leukocyte rolling adhesion

A two-part medical pathophysiology diagram illustrating the link between metabolic dysfunction and systemic inflammation. Part A depicts the cascade where hyperglycemia and hyperlipidemia generate Damage-Associated Molecular Patterns (DAMPs). These molecules bind to Toll-like receptors (TLRs) on macrophages and dendritic cells, triggering the release of pro-inflammatory cytokines (TNFͱ, IL-1̢, IL-6). This lead to leukocyte migration into insulin-dependent tissues and systemic low-grade chronic inflammation. An inset showing the vascular compartment details the neutrophil recruitment process, highlighting decreased rolling (mediated by selectin) and increased adhesion (mediated by integrins and ICAMs). Part B focuses on the cellular impact of hyperglycemia, showing attenuated ICAM expression, decreased neutrophil degranulation, impaired Neutrophil Extracellular Trap (NET) formation, and decreased phagocytosis by neutrophils and macrophages. It also notes the transition of macrophages to the M2 phenotype at sites of infection. This diagram is designed for advanced medical education regarding the immunology of metabolic diseases like diabetes and obesity.

This pathophysiology diagram illustrates the sequential stages of the leukocyte adhesion cascade within a blood vessel or high endothelial venule (HEV). The process is divided into four main phases: Tethering, Rolling, Arrest, and Extravasation. 1. Tethering: Mediated by L-selectin and P/E-selectins interacting with their respective ligands. Leukocyte integrins are in a closed conformation. 2. Rolling: Leukocyte shape elongates as it interacts with chemokines via GPCRs. This triggers 'inside-out signaling,' shifting integrins to an open conformation. 3. Arrest: Firm adhesion is achieved through high-affinity integrin binding (VLA-4, LFA-1, Mac-1) to endothelial ligands (MAdCAM-1, ICAM-1, VCAM-1). 4. Extravasation: The leukocyte exits into the tissue/lymph node via two pathways: Paracellular migration (between endothelial cells, involving CD31, JAM, and VE-Cadherin) or Transcellular migration (through the endothelial cell, involving F-actin). The diagram concludes with the leukocyte passing the basement membrane and pericytes, directed by chemotaxis. This visual is designed for advanced immunology and medical students to understand cellular recruitment during inflammation or immune surveillance.

Reading File

Searching Images

granuloma chronic inflammation macrophage epithelioid

This is a low-magnification brightfield histology image of a tissue section stained with Hematoxylin and Eosin (H&E). The specimen shows granulomatous inflammation with aggregates of epithelioid macrophages forming a rounded granuloma, often with multinucleated giant cells, surrounded by a lymphocytic cuff. The central focus is well circumscribed within native parenchyma, suggesting a chronic, organized immune response to a persistent antigen. Necrosis is not clearly evident at this magnification, though subtle caseation cannot be excluded. Morphology is compatible with tuberculoid or non-caseating granulomas, and infectious versus noninfectious etiologies must be distinguished with ancillary studies. This pattern can occur in lymph nodes or solid organs and prompts a differential that includes tuberculous lymphadenitis, sarcoidosis, fungal granulomatous infections (Histoplasma, Coccidioides), and foreign-body reaction. Clinically, recognition of granulomas guides testing: acid-fast bacilli staining (Ziehl-Neelsen), fungal stains (GMS/PAS), cultures, PCR panels, and radiologic correlation. The image is educational for medical trainees, illustrating granuloma architecture, macrophage differentiation, and the spectrum of chronic inflammatory responses. Educational context.

Imaging modality: Light microscopy; Technique: Hematoxylin and eosin staining; Specimen: Tissue biopsy; Magnification: 400x. The slide depicts a granular inflammatory tissue with chronic granulomatous features. Epithelioid histiocytes are arranged in nodular clusters, interspersed with multinucleated giant cells. The background shows a mixed inflammatory infiltrate dominated by small lymphocytes and occasional plasma cells. Blood vessels with mild perivascular inflammation are present, and the stromal framework appears fibrous in places. In several fields there are well-demarcated granuloma-like aggregates, while elsewhere the architecture is disrupted by focal necrotic debris and amorphous pink extracellular matrix. Notable features include coalescing macrophage-rich nodules and a few eosinophils; occasional foamy macrophages may be seen. The overall pattern is compatible with chronic granulomatous inflammation. Pathological significance: suggests a granulomatous process, prompting differential diagnoses such as infectious etiologies (mycobacterial, fungal) or noninfectious conditions like sarcoidosis or foreign-body reaction. Recommended ancillary studies: Ziehl-Neelsen or acid-fast stains, Gomori methenamine silver or PAS stains, fungal cultures, and targeted immunohistochemistry as indicated. Clinical correlation with patient history, imaging, and microbiology is essential for etiologic determination and guiding management. Clinical utility: this image serves as an educational reference for understanding granulomatous pathology in biopsy specimens and for teaching interpretation of epithelioid histiocytes, giant cells, and necrotic changes.

I now have comprehensive content from Robbins Pathology. Let me compile the full teaching guide.

🔥 Inflammation: Acute & Chronic - Complete Teaching Guide with Mnemonics

Based on Robbins, Cotran & Kumar Pathologic Basis of Disease and Robbins & Kumar Basic Pathology

PART 1: THE FOUNDATION - What is Inflammation?

Inflammation is a protective response by vascularized tissues to eliminate the cause of cell injury, dead cells, and damaged tissue - and to initiate repair. Without it, infections would go unchecked and wounds would never heal.

The Cardinal Signs (Celsus + Virchow): "PRISH"

R - Rubor (Redness) - from vasodilation
P - (h)eat - Calor - from increased blood flow
I - Increased blood flow = 2nd component
S - Swelling - Tumor - from fluid exudation
H - Heat - from vasodilation

Better mnemonic: "SHARP"

S - Swelling (Tumor)
H - Heat (Calor)
A - redness (ruboR)
R - Pain (doloR) - added by Virchow
P - Loss of function (added by Virchow) - Paralysis of function

PART 2: ACUTE INFLAMMATION

Definition

A rapid, short-lived (minutes to days) response to cell injury, characterized by exudation of fluid and leukocytes - especially neutrophils - into the affected tissue.

The Three Components: "FPL"

F - Flow changes: vasodilation → increased blood flow (heat + redness)
P - Permeability increase: protein-rich fluid exits vessels (swelling)
L - Leukocyte emigration: neutrophils leave vessels, accumulate at injury site

2A: VASCULAR CHANGES

The sequence: "VaSPer"

Vasodilation - histamine acts on smooth muscle of post-capillary venules → increased blood flow (heat + redness)
Stasis - increased permeability → fluid leaves → RBCs concentrate → flow slows
Permeability increase - protein-rich exudate pours out → edema/swelling

Exudate vs Transudate:

Feature	Exudate	Transudate
Protein	High	Low (mostly albumin)
Cause	Inflammation (increased permeability)	Hydrostatic/osmotic pressure
Example	Pus, fibrinous fluid	Heart failure edema

Mnemonic: "Exudate = Exciting inflammation; Transudate = Tranquil, no inflammation"

2B: LEUKOCYTE RECRUITMENT - The 4-Step Cascade

This is the most heavily tested topic. The steps are:

Mnemonic: "RAMT" = "Rolling Across My Terrain"

Step	Process	Key Molecules
1. Rolling (Margination)	Neutrophils loosely tumble along endothelium	Selectins (P, E, L-selectin) bind sialyl-Lewis X
2. Adhesion (Firm)	Tight binding to endothelium	Integrins (LFA-1, MAC-1) bind ICAM-1; VLA-4 binds VCAM-1
3. Migration (Transmigration/Diapedesis)	Squeezing through endothelial junctions	CD31 (PECAM-1) - homotypic interaction
4. Taxis (Chemotaxis)	Directed movement toward injury	Complement C5a, LTB4, IL-8, bacterial products (fMLP)

Leukocyte adhesion cascade - rolling, arrest, and extravasation

The complete leukocyte adhesion cascade: Tethering → Rolling (selectins) → Arrest (integrins) → Extravasation (CD31/PECAM-1)

Selectin mnemonic: "PEL Selectins"

P-selectin: expressed on Platelets and endothelium (stored in Weibel-Palade bodies, rapidly mobilized by histamine/thrombin)
E-selectin: expressed on Endothelium only (activated by TNF, IL-1)
L-selectin: expressed on Leukocytes (neutrophils, monocytes, T-cells)

Integrin mnemonic: "LFA MAC VLA"

LFA-1 (CD11a/CD18): on neutrophils/T-cells → binds ICAM-1, ICAM-2
MAC-1 (CD11b/CD18): on monocytes/DCs → binds ICAM-1
VLA-4 (CD49d/CD29): on monocytes/T-cells → binds VCAM-1

2C: PHAGOCYTOSIS

"ROK" sequence:

Recognition and attachment (opsonization by IgG, C3b)
Opsonization - coating with antibodies/complement to enhance phagocytosis
Kill (intracellular killing) - ROS, NO, lysosomal enzymes

Killing mechanisms: "RON"

Reactive Oxygen Species (ROS) - "respiratory burst" via NADPH oxidase → H2O2 → HOCl (bleach!)
Oxide - Nitric oxide (NO) - via iNOS
Nitrogen + other mechanisms - MPO (myeloperoxidase), lysozyme, defensins

Neutrophil Extracellular Traps (NETs): Neutrophils can die by expelling chromatin + enzymes to trap extracellular bacteria.

2D: OUTCOMES OF ACUTE INFLAMMATION: "RASH"

R - Resolution (complete restoration - best outcome, minimal damage)
A - Abscess formation (walled-off pus)
S - Scarring/fibrosis (extensive necrosis → repair by fibrosis)
H - leads to chronic inflammation (persistent stimulus)

PART 3: CHEMICAL MEDIATORS OF INFLAMMATION

This is the most complex and most tested area. Organize them by SOURCE:

Master Mnemonic: "PACK + BKP + CNOPF"

PLASMA-DERIVED mediators:

P - Plasmin (fibrinolytic system)
A - Alternative/Classical/Lectin pathways (Complement)
C - Coagulation/Kinin system
K - Kinins (Bradykinin)

CELL-DERIVED mediators:

P - Prostaglandins
B - Bradykinin
K - Kinins
P - PAF (Platelet Activating Factor)

Let's learn each group systematically:

MEDIATOR GROUP 1: VASOACTIVE AMINES - "His & Sero"

HISTAMINE - "His MAST"

Source: MAST cells (mast cells, basophils, platelets)
Stored preformed in granules - released FAST
Triggers: Physical injury, IgE, C3a/C5a, IL-1
Actions: Vasodilation + increased vascular permeability (postcapillary venules)
Mnemonic: "Histamine Hates blood staying in vessels - it opens the gates"

SEROTONIN (5-HT)

Source: Platelets (stored in dense granules)
Similar actions to histamine
Also a neurotransmitter
Mnemonic: "Sero = Stored in platelet granules"

MEDIATOR GROUP 2: ARACHIDONIC ACID (AA) METABOLITES (EICOSANOIDS)

This is the MOST important group for pharmacology (NSAIDs, steroids, leukotriene antagonists all target this pathway).

Arachidonic acid is released from membrane phospholipids by PHOSPHOLIPASE A2

Two main pathways:

Membrane Phospholipids
        ↓ (Phospholipase A2 - blocked by CORTICOSTEROIDS via lipocortin)
  Arachidonic Acid
    /            \
COX pathway    LOX pathway
(Cyclooxygenase)  (Lipoxygenase)
    ↓                 ↓
Prostaglandins    Leukotrienes
Thromboxane A2    LTB4, LTC4, LTD4, LTE4
Prostacyclin (PGI2)

Master Mnemonic for AA metabolites: "COX Makes PTP; LOX Makes BDE"

COX (Cyclooxygenase) products:

Prostaglandins (PGD2, PGE2, PGF2α)
Thromboxane A2
Prostacyclin (PGI2)

LOX (Lipoxygenase) products:

B = LTB4 (chemotaxis of neutrophils)
D = LTD4 (bronchoconstriction - main mediator in asthma)
E = LTE4 (bronchoconstriction)
(LTC4 also causes bronchoconstriction)

PROSTAGLANDINS - Mnemonic: "PGE2 = Pain, Fever, Vasodilate"

Eicosanoid	Action	Mnemonic
PGI2 (Prostacyclin)	Vasodilation, ↑permeability, inhibits platelet aggregation	"PGI2 = Peace - no clots"
PGE2, PGD2	Vasodilation, ↑permeability, PAIN, FEVER	"E2 = Everything bad (pain+fever)"
TXA2 (Thromboxane A2)	Vasoconstriction, platelet aggregation	"TX = TighteX blood vessels"
LTB4	Chemotaxis of neutrophils	"B4 = Brings neutrophils Before others"
LTC4, LTD4, LTE4 (cysteinyl leukotrienes)	Bronchoconstriction, ↑vascular permeability	"CDE = Constrict During Exercise (asthma!)"

Drug targets:

NSAIDs (aspirin, ibuprofen): block COX → reduce prostaglandins → reduce pain, fever, inflammation
Aspirin (irreversible COX inhibitor): also blocks TXA2 → antiplatelet effect
Montelukast/Zafirlukast: block LTC4/LTD4 receptors → treat asthma
Zileuton: blocks 5-lipoxygenase → blocks all leukotrienes
Corticosteroids: block Phospholipase A2 → block ENTIRE AA pathway

Mnemonic: "Steroids Stop at the Source (Phospholipase A2)"

MEDIATOR GROUP 3: CYTOKINES - "TNF IL-1 IL-6 = The Terrible Inflammatory League"

TNF and IL-1: The "Dynamic Duo" of inflammation

Both produced primarily by macrophages and have overlapping actions:

Local effects:

Endothelial activation → upregulate adhesion molecules (selectins, ICAM-1, VCAM-1)
Increased permeability
Stimulate prostaglandin production

Systemic effects (acute-phase response) - Mnemonic: "FAS":

F - Fever (via PGE2 in hypothalamus)
A - Acute phase proteins (CRP, fibrinogen, SAA - made by liver in response to IL-6!)
S - Septic shock (massive TNF → vasodilation, DIC, multi-organ failure)

IL-6: "The Liver Lover"

Made by macrophages
Acts on liver → stimulates acute phase protein production (CRP, fibrinogen)
Also involved in local and systemic inflammatory reactions
Anti-IL-6 receptor (tocilizumab) is used in juvenile arthritis

IL-17: "The Neutrophil Caller"

Produced by Th17 cells
Promotes neutrophil recruitment (via chemokine production)
Target in psoriasis treatment (secukinumab/ixekizumab block IL-17)

CHEMOKINES: "Directed Traffic Controllers"

Chemokines are a subclass of cytokines that specifically drive chemotaxis
IL-8 (CXCL8) = most important - made by macrophages/endothelium → recruits neutrophils
CXCR4, CCR5: receptors that HIV uses to enter cells!
Mnemonic: "Chemokines = Chemical GPS for leukocytes"

MEDIATOR GROUP 4: COMPLEMENT SYSTEM - "The C3 Pivot"

Three activation pathways: "CAL"

Classical: antibody (IgG or IgM) binds antigen → activates C1 → C4/C2 → C3
Alternative: microbial surfaces (LPS, endotoxin) spontaneously activate in absence of antibody
Lectin: mannose-binding lectin (MBL) binds carbs on microbes → activates C3

C3 is the convergence point of all three pathways

Key complement fragments - Mnemonic: "C3b Coats, C5a Calls, MAC Kills"

Fragment	Function	Mnemonic
C3b	Opsonization (coats microbes for phagocytosis)	"3b = 3 Bugs get Coated"
C3a, C5a	Anaphylatoxins → trigger mast cell degranulation → histamine release → ↑permeability, vasodilation	"3a/5a = Anaphylatoxins Alarm mast cells"
C5a	Chemotaxis for neutrophils (the most potent chemotactic complement fragment)	"5a = Five-alarm chemotaxis"
C5b-9	MAC (Membrane Attack Complex) → lyses cell membranes	"5-9 = MAC = Murder All Cells"

MEDIATOR GROUP 5: KININ SYSTEM - "Brady-kinin = Slow + Pain"

Bradykinin is the main mediator
Formed from kininogens by kallikrein (activated by Hageman factor/Factor XII)
Actions: vasodilation, ↑permeability, pain (potentiated by PGE2), bronchospasm
Very short half-life (degraded by kininase/ACE)
Mnemonic: "Brady = Slow acting; 'kinin' = pain"

ACE inhibitor side effect - cough: ACE normally degrades bradykinin. When ACE is inhibited → bradykinin accumulates → cough + angioedema

MEDIATOR GROUP 6: PLATELET ACTIVATING FACTOR (PAF)

Source: many cells - mast cells, basophils, platelets, neutrophils
Actions: platelet aggregation, bronchoconstriction, ↑permeability (10,000x more potent than histamine!), vasodilation
Mnemonic: "PAF = Powerful Amplification Factor"

MEDIATOR GROUP 7: NITRIC OXIDE (NO)

Produced by: endothelial cells (eNOS), macrophages (iNOS)
Actions:
- Vasodilation (relaxes smooth muscle - same as nitroglycerin mechanism)
- Antimicrobial - kills microbes in macrophages
- Reduces platelet aggregation
Mnemonic: "NO = Nasty to microbes, Nice to vessels (dilates them)"

MEDIATOR MASTER SUMMARY TABLE

Mediator	Source	Vasodilation	↑Permeability	Chemotaxis	Pain/Fever
Histamine	Mast cells, basophils	✓	✓	-	-
Serotonin	Platelets	✓	✓	-	-
PGE2/PGI2	Many cells	✓	✓	-	✓ (PGE2)
TXA2	Platelets	✗ (constricts)	-	-	-
LTB4	Leukocytes	-	-	✓✓✓	-
LTC4/D4/E4	Mast cells	-	✓	-	-
C3a/C5a	Plasma (complement)	✓	✓	✓ (C5a)	-
IL-1, TNF	Macrophages	✓	✓	-	✓
IL-8	Macrophages, endothelium	-	-	✓✓	-
Bradykinin	Plasma	✓	✓	-	✓✓
NO	Endothelium, macrophages	✓	-	-	-
PAF	Mast cells, platelets	✓	✓✓✓	-	-

PART 4: MORPHOLOGICAL PATTERNS OF ACUTE INFLAMMATION

Mnemonic: "SUPF"

Serous - watery exudate (e.g., skin blister, pleural fluid early viral infection); low protein
Ulcer - epithelial defect from necrosis (e.g., peptic ulcer, pressure sore)
Purulent/Suppurative - pus = neutrophils + necrotic cells + microbes (e.g., abscess, empyema)
Fibrinous - fibrin-rich exudate (e.g., fibrinous pericarditis = "bread-and-butter" appearance)

PART 5: CHRONIC INFLAMMATION

Definition

A prolonged response (weeks to months) in which inflammation, tissue injury, and repair coexist simultaneously - the hallmark distinction from acute inflammation.

Causes - Mnemonic: "PHA"

P - Persistent infections (mycobacteria, fungi, parasites - organisms that resist eradication)
H - Hypersensitivity/autoimmune diseases (RA, IBD, SLE, multiple sclerosis) - self-perpetuating T/B cell reaction
A - Agents (toxic) - silica → silicosis; cholesterol → atherosclerosis

Morphological Features - Mnemonic: "MIT"

Mononuclear infiltrate (macrophages, lymphocytes, plasma cells - NOT neutrophils!)
Injury/tissue destruction (ongoing)
Tissue repair by fibrosis/angiogenesis (simultaneous)

Key Cells: "MLEPO"

Macrophages - dominant cell; the "directors" of chronic inflammation
Lymphocytes (T and B cells)
Eosinophils (especially in parasitic/allergic inflammation)
Plasma cells (secrete antibodies)
Other: mast cells, fibroblasts

THE MACROPHAGE: Director of Chronic Inflammation

Macrophages are derived from circulating monocytes that emigrate into tissues. They have TWO polarization states:

Mnemonic: "M1 = Meanest Killer; M2 = Mellow Healer"

Type	Activation	Functions
M1 (classical)	IFN-γ (from Th1 cells), LPS	Kill microbes, produce ROS, NO, IL-1, TNF, IL-12 → pro-inflammatory
M2 (alternative)	IL-4, IL-13 (from Th2 cells)	Anti-inflammatory, tissue repair, fibrosis, produce IL-10, TGF-β

Macrophage actions in chronic inflammation: "STACK"

Secrete cytokines (TNF, IL-1, IL-12, IL-6)
Tissue damage (proteases, elastase, collagenase)
Antigen presentation (to T-cells via MHC)
Chemokine secretion (recruit more leukocytes)
Kill microbes (ROS, NO, lysosomal enzymes)

T LYMPHOCYTES IN CHRONIC INFLAMMATION

The Three T-helper subsets - Mnemonic: "1 Fights, 2 Allergies, 17 Neutrophils"

T-helper	Cytokine secreted	Role
Th1	IFN-γ	Activates M1 macrophages → kills intracellular bacteria; drives autoimmune disease
Th2	IL-4, IL-5, IL-13	Activates M2 macrophages; recruits eosinophils; drives allergy, asthma, helminth defense
Th17	IL-17	Recruits neutrophils + monocytes; drives psoriasis, some autoimmune diseases

Bidirectional macrophage-lymphocyte interaction:

Macrophage presents antigen → activates T-cells
T-cells secrete IFN-γ → activates macrophages → more antigen presentation
This SELF-PERPETUATING cycle maintains chronic inflammation

Macrophage-lymphocyte bidirectional interaction in chronic inflammation

Bidirectional macrophage-T lymphocyte interaction: macrophages activate T-cells, and T-cell cytokines (IFN-γ, IL-17) further activate macrophages in a self-amplifying loop

PART 6: GRANULOMATOUS INFLAMMATION

The special subtype of chronic inflammation - the highest-yield topic in exams.

Definition

A pattern of chronic inflammation formed by clusters of activated macrophages (epithelioid cells) surrounding a persistent, indigestible stimulus. Giant cells form by fusion of multiple macrophages.

What triggers granuloma formation?

T-cell AND macrophage activation against an agent that CANNOT be eliminated

Components of a granuloma: "EAGLE"

E - Epithelioid cells (activated macrophages - elongated, pink cytoplasm, look like squamous epithelium)
A - Aggregate (central cluster of epithelioid cells)
G - Giant cells (Langhans type: nuclei arranged in horseshoe; Foreign body type: nuclei scattered randomly)
L - Lymphocytes (surrounding the granuloma)
E - Extra fibrosis (surrounding cuff of fibroblasts)

Granulomatous inflammation with epithelioid macrophages and giant cells

Granuloma: central epithelioid macrophages + multinucleated giant cells, surrounded by lymphocytic cuff - the hallmark of chronic granulomatous inflammation

Types of granulomas: "Case Closed vs Not Closed"

Type	Features	Disease
Caseating (necrotizing)	Cheesy central necrosis (caseum)	Tuberculosis (most classic)
Non-caseating	No necrosis	Sarcoidosis, Crohn's disease, leprosy (tuberculoid), Berylliosis

Diseases with granulomas - Mnemonic: "SCLBT-CGF"

S - Sarcoidosis (non-caseating, unknown etiology)
C - Crohn's disease (non-caseating, GI wall)
L - Leprosy (non-caseating in tuberculoid type)
B - Berylliosis (non-caseating)
T - Tuberculosis (caseating, Langhans giant cells, acid-fast bacilli)
C - Cat-scratch disease (stellate granuloma with central neutrophils)
G - syphilis/Gumma (plasma cells prominent)
F - Fungal infections (Histoplasma, Coccidioides)

PART 7: SYSTEMIC EFFECTS OF INFLAMMATION (Acute Phase Response)

Triggered by: TNF, IL-1, IL-6

Systemic manifestations - Mnemonic: "FLAP"

F - Fever (IL-1/TNF → PGE2 in hypothalamus → raises set point)
L - Leukocytosis (IL-1/TNF → bone marrow release of WBCs; left shift = band cells)
A - Acute phase proteins (IL-6 → liver → CRP, fibrinogen, SAA, complement proteins)
P - Protein catabolism (wasting, cachexia - TNF = "cachectin")

Acute Phase Proteins: "CFS" = CRP, Fibrinogen, SAA

CRP (C-reactive protein): binds phosphocholine on microbes → opsonization + complement activation
Fibrinogen: causes RBC rouleaux → elevated ESR
SAA (serum amyloid A): can deposit as amyloid if overproduced chronically

PART 8: ACUTE vs CHRONIC INFLAMMATION - MASTER COMPARISON

Feature	Acute	Chronic
Duration	Minutes to days	Weeks to months
Dominant cell	Neutrophil	Macrophage
Other cells	Mast cells, basophils, platelets	Lymphocytes, plasma cells, eosinophils
Vascular changes	Prominent (vasodilation, permeability)	Less prominent
Tissue injury	Usually less severe	Prominent, ongoing
Fibrosis	Absent	Common
Outcome	Resolution, abscess, scar, or → chronic	Fibrosis, functional loss

Mnemonic: "Acute = Neutrophils; Chronic = Macrophages" - the single most important distinction.

PART 9: PHARMACOLOGY CONNECTIONS

Drug	Target	What it blocks
Corticosteroids	Phospholipase A2 (via lipocortin)	Entire AA pathway (all prostaglandins + leukotrienes)
NSAIDs/COX inhibitors	Cyclooxygenase (COX-1/COX-2)	Prostaglandins + TXA2
Aspirin (irreversible)	COX in platelets	TXA2 → antiplatelet effect
Montelukast, Zafirlukast	Leukotriene receptors (CysLT1)	LTC4/LTD4/LTE4 → for asthma
Zileuton	5-Lipoxygenase	All leukotrienes
Antihistamines (H1 blockers)	H1 receptor	Histamine effects (allergy)
Anti-TNF (infliximab, adalimumab)	TNF-α	Chronic inflammation in RA, IBD, psoriasis
Tocilizumab	IL-6 receptor	Juvenile arthritis, rheumatoid arthritis
Secukinumab	IL-17A	Psoriasis

PART 10: MASTER MNEMONICS FLASHCARD

Topic	Mnemonic
Cardinal signs	SHARP (Swelling, Heat, redness, Pain, loss of function)
Acute inflammation components	FPL (Flow, Permeability, Leukocytes)
Leukocyte recruitment	RAMT (Rolling, Adhesion, Migration, Taxis)
Selectins	PEL (P on platelets, E on endothelium, L on leukocytes)
AA pathway	COX → "PTP" (Prostaglandins, TXA2, PGI2); LOX → LTBDE
Eicosanoid actions	TXA2 = "TighteX" (constricts/clots); PGI2 = "Peace" (dilates/anti-platelet); LTB4 = "Brings" neutrophils; CDE = "Constrict" (asthma)
Complement	C3b = Coats; C3a/C5a = Anaphylatoxins; C5a = Chemotaxis; C5b-9 = MAC
Kinin	Bradykinin = "Slow + Pain"; ACE inhibitor → bradykinin accumulates → cough
Cytokines	TNF/IL-1/IL-6 = "FAS" (Fever, Acute phase, Septic shock)
Chronic inflammation cells	MLEPO (Macrophages, Lymphocytes, Eosinophils, Plasma cells, Others)
Macrophage polarization	M1 = "Meanest Killer"; M2 = "Mellow Healer"
T-helper subsets	Th1 = IFN-γ + macrophage activation; Th2 = IL-4/5/13 + allergy; Th17 = IL-17 + neutrophils
Granuloma	EAGLE (Epithelioid, Aggregate, Giant cells, Lymphocytes, fEnce of fibroblasts)
Caseating vs non-caseating	TB = Caseating (necrosis); Sarcoid/Crohn = Non-caseating
Systemic effects	FLAP (Fever, Leukocytosis, Acute phase proteins, Protein catabolism)

Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease (9780443264528); Robbins & Kumar Basic Pathology (9780323790185)

This is a shared conversation. Sign in to Orris to start your own chat.